Several countries in Europe are now discouraging giving puberty blockers to children as the "outlier" U.S. continues to defend the treatment, according to a new report. The United Kingdoms National Health Service limited the use of puberty blockers for clinical research this month, according to its website, citing "significant uncertainties surrounding the use of hormone treatments." MORE AT Europe breaks against puberty blockers as US becomes 'outlier' in defending treatments for transgender minors (msn.com)
No comments:
Post a Comment